Literature DB >> 18026996

Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin.

Gian Marco Ghiggeri1, Dario Bleid, Alberto Garaventa, Cristina Coccia, Claudio Gambini, Gianluca Caridi, Francesco Perfumo.   

Abstract

We report on a 10-year-old child with nephrotic syndrome who developed recurrent lymphomatoid papulosis (LYP) 60 months after the first episode of proteinuria. LYP appeared when the child was taking low-dose cyclosporin and disappeared after the drug was replaced by prednisone at doses utilized for nephrotic syndrome (2 mg/kg). During the tapering of steroids, when the child was treated with low-dose prednisone (0.2 mg/kg), both LYP and nephrotic syndrome started again and required the reintroduction of prednisone to restore a normal clinical situation. This is the first case of LYP occurring in concomitance and synchronous with nephrotic syndrome. LYP was unrelated to cyclosporin (second episode after its withdrawn) but preceded the recurrence of proteinuria, suggesting a relationship with the disease activity. Even though the etiology of LYP is, in this case, uncertain, it should be considered as a clinical association of nephrotic syndrome in children and also included among potential triggers of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026996     DOI: 10.1007/s00467-007-0667-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening.

Authors:  Djillali Sahali; André Pawlak; Asta Valanciuté; Philippe Grimbert; Philippe Lang; Philippe Remy; Albert Bensman; Georges Guellën
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 2.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.

Authors:  R Willemze; H Kerl; W Sterry; E Berti; L Cerroni; S Chimenti; J L Diaz-Peréz; M L Geerts; M Goos; R Knobler; E Ralfkiaer; M Santucci; N Smith; J Wechsler; W A van Vloten; C J Meijer
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.

Authors:  G S Wood; D L Hardman; R Boni; R Dummer; Y H Kim; B R Smoller; M Takeshita; M Kikuchi; G Burg
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

Review 4.  Molecular biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

Review 5.  The role of cytokines in classical Hodgkin lymphoma.

Authors:  Brian F Skinnider; Tak W Mak
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

6.  The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.

Authors:  J F DeCoteau; J R Butmarc; M C Kinney; M E Kadin
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

Review 7.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature.

Authors:  V Audard; F Larousserie; P Grimbert; M Abtahi; J-J Sotto; A Delmer; F Boue; D Nochy; N Brousse; R Delarue; P Remy; P Ronco; D Sahali; P Lang; O Hermine
Journal:  Kidney Int       Date:  2006-05-03       Impact factor: 10.612

Review 8.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

9.  Lymphoproliferative disorders in Oxford renal transplant recipients.

Authors:  W D Bates; D W R Gray; M A Dada; R Chetty; K C Gatter; D R Davies; P J Morris
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

10.  CD30(+) cutaneous lymphoma in association with atopic eczema.

Authors:  Clair L Fletcher; Guy E Orchard; Virginia Hubbard; Sean J Whittaker; Richard L Edelson; Robin Russell-Jones
Journal:  Arch Dermatol       Date:  2004-04
View more
  2 in total

1.  Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases.

Authors:  Tomek Kofman; Shao-Yu Zhang; Christiane Copie-Bergman; Anissa Moktefi; Quentin Raimbourg; Hélène Francois; Alexandre Karras; Emmanuelle Plaisier; Bernard Painchart; Guillaume Favre; Dominique Bertrand; Emmanuel Gyan; Marc Souid; Damien Roos-Weil; Dominique Desvaux; Philippe Grimbert; Corinne Haioun; Philippe Lang; Djillali Sahali; Vincent Audard
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

2.  Pathophysiological lessons from rare associations of immunological disorders.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.